Arch Biopartners Inc. (ACHFF)
OTCMKTS · Delayed Price · Currency is USD
0.3465
-0.0065 (-1.84%)
Jun 16, 2026, 12:41 PM EST
Arch Biopartners Market Cap
Arch Biopartners has a market cap or net worth of $23.98 million as of June 16, 2026. Its market cap has decreased by -72.22% in one year.
Market Cap
23.98M
Enterprise Value
25.62M
Revenue
113.25K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.35
Market Cap Chart
Since January 21, 2011, Arch Biopartners's market cap has decreased from 33.63M to 23.98M, a decrease of -28.68%. That is a compound annual growth rate of -2.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 23.98M | -59.44% |
| Dec 31, 2025 | 59.13M | -32.56% |
| Dec 31, 2024 | 87.67M | 25.12% |
| Dec 29, 2023 | 70.07M | -46.02% |
| Dec 30, 2022 | 129.79M | -23.83% |
| Dec 31, 2021 | 170.40M | 138.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vicapsys Life Sciences | 47.26M |
| Provectus Biopharmaceuticals | 25.47M |
| EOM Pharmaceuticals Holdings | 24.05M |
| Oncotelic Therapeutics | 21.38M |
| Anebulo Pharmaceuticals | 19.36M |
| LianBio | 17.30M |
| ZIVO Bioscience | 15.24M |
| Inhibitor Therapeutics | 14.75M |